1. Home
  2. Analysis
  3. Metolazone
  4. Baycol

Metolazone and Baycol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metolazone and Baycol. Common interactions include chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Metolazone and Baycol have. It is created by eHealthMe based on reports of 6 people who take Metolazone and Baycol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

6 people who take Metolazone and Baycol together, and have interactions are studied.

What is Metolazone?

Metolazone has active ingredients of metolazone. It is often used in swelling. eHealthMe is studying from 12,267 Metolazone users for its effectiveness, alternative drugs and more.

What is Baycol?

Baycol has active ingredients of cerivastatin sodium. eHealthMe is studying from 19,129 Baycol users for its effectiveness, alternative drugs and more.

Number of Metolazone and Baycol reports submitted per year:

Metolazone and Baycol drug interactions.

Common Metolazone and Baycol drug interactions by gender *:

female:

n/a

male:

  1. Chronic kidney disease
  2. Renal failure
  3. Acquired phimosis
  4. Activities of daily living impaired
  5. Acute prerenal failure
  6. Alcohol abuse
  7. Alopecia
  8. Anaemia
  9. Angina pectoris
  10. Angioplasty

Common Metolazone and Baycol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Acquired phimosis
  3. Activities of daily living impaired
  4. Acute prerenal failure
  5. Alcohol abuse
  6. Alopecia
  7. Anaemia
  8. Angina pectoris
  9. Angioplasty
  10. Anxiety

60+:

  1. Chronic kidney disease
  2. Cardiac arrest
  3. Death
  4. Gangrene
  5. Hyperkalaemia
  6. Nephrogenic anaemia
  7. Renal failure
  8. Renal failure acute
  9. Septic shock

* Approximation only. Some reports may have incomplete information.

Do you take Metolazone and Baycol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Metolazone and Baycol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Metolazone side effects:

Browse all side effects of Metolazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Baycol side effects:

Browse all side effects of Baycol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Metolazone interactions:

Browse all interactions between Metolazone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Baycol interactions:

Browse all interactions between Baycol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metolazone and cerivastatin sodium (the active ingredients of Metolazone and Baycol, respectively), and Metolazone and Baycol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Metolazone and Baycol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.